Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially predict Alzheimer’s disease three and a half years before clinical diagnosis.
Their findings were published in Brain, showing that components in blood can modulate neurogenesis, which is the formulation of new brain cells, in the hippocampus. Alzheimer’s affects neurogenesis in the hippocampus in the early stages of the disease, however, previous studies only evaluated neurogenesis in the later stages.
